nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cancer in public figures, 2010-2020
|
Benjamin, D.J. |
|
|
7 |
C |
p. |
artikel |
2 |
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data
|
Delombaerde, D. |
|
|
7 |
C |
p. |
artikel |
3 |
Characterisation of oncology EHR-derived real-world data in the UK, Germany, and Japan
|
Adamson, B. |
|
|
7 |
C |
p. |
artikel |
4 |
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)
|
Acebedo, A. |
|
|
7 |
C |
p. |
artikel |
5 |
Core variables for real-world clinicogenomic data collection in precision oncology
|
Dienstmann, R. |
|
|
7 |
C |
p. |
artikel |
6 |
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records
|
Mazzeo, L. |
|
|
7 |
C |
p. |
artikel |
7 |
Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review
|
Verschueren, M.V. |
|
|
7 |
C |
p. |
artikel |
8 |
Editoiral Board
|
|
|
|
7 |
C |
p. |
artikel |
9 |
Evolving treatment patterns and outcomes among patients with metastatic urothelial carcinoma post-avelumab maintenance approval: insights from The US Oncology Network
|
Li, H. |
|
|
7 |
C |
p. |
artikel |
10 |
Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
|
George, G. |
|
|
7 |
C |
p. |
artikel |
11 |
Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study
|
López-Miranda, E. |
|
|
7 |
C |
p. |
artikel |
12 |
Impact of travel costs on disparities in precision oncology clinical trials
|
Uehara, Y. |
|
|
7 |
C |
p. |
artikel |
13 |
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
|
Kita, Y. |
|
|
7 |
C |
p. |
artikel |
14 |
Neutrophil to lymphocyte ratio and tumour burden for treatment efficacy stratification in renal cell carcinoma patients receiving nivolumab plus ipilimumab
|
Oshima, M. |
|
|
7 |
C |
p. |
artikel |
15 |
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach
|
Cioli, E. |
|
|
7 |
C |
p. |
artikel |
16 |
Perspectives, willingness, and current use of mobile health (mHealth) by patients with cancer for remote monitoring during cancer treatment: a Dutch national cross-sectional survey ☆
|
Stuijt, D.G. |
|
|
7 |
C |
p. |
artikel |
17 |
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
|
Macarulla, T. |
|
|
7 |
C |
p. |
artikel |
18 |
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study
|
Fountzilas, E. |
|
|
7 |
C |
p. |
artikel |
19 |
Reply to the Correspondence regarding “Sequencing the anti-EGFR-TKIs; route to the longest survival” by H.G. Güzel et al.
|
Uehara, Y. |
|
|
7 |
C |
p. |
artikel |
20 |
Table of Contents
|
|
|
|
7 |
C |
p. |
artikel |
21 |
Utility of automated data transfer for cancer clinical trials and considerations for implementation
|
Pfeffer, M. |
|
|
7 |
C |
p. |
artikel |